Abstract

Sugar-based biopolymers have emerged as a versatile and promising class of materials in the field of nanomedicine, particularly in cancer imaging and therapy. These biopolymers, derived from naturally occurring sugars, offer unique properties such as biocompatibility, biodegradability, and the ability to interact with biological molecules, making them ideal for targeted cancer applications. This review highlights recent advancements in the development of sugar-based biopolymer Nano carriers for cancer imaging and therapy. We discuss their role in enhancing the specificity and efficacy of drug delivery systems, improving imaging techniques, and reducing side effects associated with conventional cancer treatments. By exploring the mechanisms of action, material design, and clinical potential, this study underscores the transformative impact of sugar-based biopolymers in the next generation of cancer diagnostics and therapeutics.